Device Trial Radar · NCT07890233
Efficacy of an LED Mask
Last checked: Nov 20, 2026Latest source record: Oct 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
110
Planned (sponsor's estimate)
Start
Nov 30, 2026
Primary completion
Mar 30, 2027
Study completion May 31, 2027
Sponsor
- Lead sponsor
- Therabody, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 22, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 25 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this interventional study is to evaluate the efficacy and perception a commercial LED device in 110 healthy adult females and males between the ages of 35-65 years old, inclusively. The main questions it aims to answer are: Does daily use of this commercial LED device improve overall skin appearance as measured by clinical tools (expert clinical grading, cutometer, digital photography, and VISIA-CR? Does daily use of this commercial LED device improve subjective skin appearance? Is daily use of this commercial LED device well tolerated? Participants will complete a 9-minute LED treatment (4.5 minutes LED, 4.5 minutes LED+ infrared light therapy) with a commercially available device every day for 12 weeks. They will visit the clinic three times (baseline, 6 weeks, 12 weeks) for clinical grading of skin.
Conditions
- Fine Lines and Wrinkles
- Skin Health
- Skin Tone
Interventions
Light emitting diode treatmentDevice
Participants will use the device for a 9-minute treatment (4.5 min red light and 4.5 minutes red + infrared light therapy) 7 days a week for 12 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Expert Clinical GradingTime frame: From enrollment to the end of treatment at 12 weeks
5 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
ALS Global Clinical Studies
Purchase, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.